ABCB1 and cancer: While certain drugs have been designed to inhibit ABCB1 activity, aiming to enhance the effectiveness of cancer therapies, such as the calcium channel blocker verapamil, a major concern arises from the expression of these transporters also in normal cells, which may result in unacceptable toxicity [34,35].